National Center for Environmental Health/Agency for Toxic Substances and Disease Registry, 77398-77399 [05-24639]
Download as PDF
77398
Federal Register / Vol. 70, No. 250 / Friday, December 30, 2005 / Notices
Dated: December 23, 2005.
Betsey Dunaway,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E5–8102 Filed 12–29–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Public Notice
Centers for Disease Control and
Prevention (CDC), Health and Human
Services (HHS).
ACTION: Notice.
wwhite on PROD1PC61 with NOTICES
AGENCY:
SUMMARY: The Centers for Disease
Control and Prevention (CDC), National
Center for Infectious Disease (NCID),
Division of Bacterial and Mycotic
Diseases (DBMD) and the National
Immunization Program, Epidemiology
and Surveillance Division through its
component Branches have lead
technical responsibility for research,
development and evaluation of
diagnostic tools for pertussis and
application of these to epidemiologic
studies of pertussis. CDC uses
epidemiologic, laboratory, clinical, and
biostatistical sciences to control and
prevent vaccine preventable infectious
diseases. CDC also conducts applied
research in a variety of settings, and
translates the findings of this research
into public health practice.
CDC is seeking to evaluate
commercial products, or products in
development, for in vitro serological
diagnosis of pertussis. Specifically these
should include tests to detect antipertussis toxin antibodies in infected
and vaccinated individuals. The tests
should be based on standardized
reagents commonly used in the field
(such as FDA Reference Serum Standard
Lot #3 or equivalents). Products will be
evaluated in CDC and collaborating
laboratories and if appropriate, may be
used in epidemiologic validation
studies. Data obtained from this
comparative analysis may be used by
CDC in making recommendations and
decisions for diagnosis of pertussis in
the public health setting.
Interested organizations that may
have candidate products are invited to
submit documentation for CDC to assess
whether the offered product(s) are at a
sufficient stage of development to be
included in this comparative analysis.
As a minimum, submitted information
should be sufficient for CDC to
determine the following for each
candidate product: (a) Product package
VerDate Aug<31>2005
19:29 Dec 29, 2005
Jkt 208001
insert or detailed instructions for use;
(b) Detailed information to determine if
the product is calibrated to a recognized
standard; and (c) Preliminary data
demonstrating suitability for validation
studies.
Organizations that have products
selected by CDC for this comparative
analysis will be required to enter into an
appropriate agreement prior to the
transfer of any material to CDC. Sample
agreements may be viewed at the
following Web site: https://www.cdc.gov/
od/ads/techtran/forms.htm. All
information submitted to CDC will be
kept confidential as allowed by relevant
federal law, including the Freedom of
Information Act (5 U.S.C. 552) and the
Trade Secrets Act (18 U.S.C. 1905). Only
information submitted within thirty
days of publication of this notice will be
reviewed to determine if the offered
product(s) will be acceptable for
possible inclusion in this comparative
analysis.
Responses are preferred in electronic
format and can be e-mailed to the
attention of Michael J. Detmer at
MDetmer@cdc.gov. Mailed responses
can be sent to the following address:
Michael J. Detmer, Division of Bacterial
and Mycotic Diseases, National Center
for Infectious Diseases, Centers for
Disease Control and Prevention, 1600
Clifton Rd., NE., Mail Stop C–09,
Atlanta, GA 30333.
FOR FURTHER INFORMATION CONTACT:
Technical: Dr. Patty Wilkins, Division of
Bacterial and Mycotic Diseases,
National Center for Infectious Diseases,
Centers for Disease Control and
Prevention (CDC), 1600 Clifton Rd., NE.,
Mail Stop D–11, Atlanta, GA 30333.
Telephone (404) 639–3297, E-Mail at
pwilkins@cdc.gov.
Business: Lisa Blake-DiSpigna,
Technology Development Coordinator,
National Center for Infectious Diseases,
Centers for Disease Control and
Prevention (CDC), 1600 Clifton Rd., NE.,
Mail Stop A–42, Atlanta, GA 30333.
Telephone (404) 639–2620, E-Mail at
LBlake-DiSpigna@cdc.gov.
Dated: December 21, 2005.
James D. Seligman,
Associate Director for Program Services,
Centers for Disease Control and Prevention.
[FR Doc. E5–8103 Filed 12–29–05; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Center for Environmental
Health/Agency for Toxic Substances
and Disease Registry
The Program Peer Review
Subcommittee of the Board of Scientific
Counselors (BSC), Centers for Disease
Control and Prevention (CDC), National
Center for Environmental Health/
Agency for Toxic Substances and
Disease Registry (NCEH/ATSDR):
Teleconference.
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), The Centers for
Disease Control and Prevention, NCEH/
ATSDR announces the following
subcommittee meeting:
Name: Program Peer Review
Subcommittee (PPRS).
Times and Dates: 12:30 p.m.–2 p.m.,
January 23, 2006.
Place: The teleconference will
originate at the National Center for
Environmental Health/Agency for Toxic
Substances and Disease Registry in
Atlanta, Georgia. Please see
SUPPLEMENTARY INFORMATION for details
on accessing the teleconference.
Status: Open to the public,
teleconference access limited only by
availability of telephone ports.
Purpose: Under the charge of the BSC,
NCEH/ATSDR the PPRS will provide
the BSC, NCEH/ATSDR with advice and
recommendations on NCEH/ATSDR
program peer review. They will serve
the function of organizing, facilitating,
and providing a long-term perspective
to the conduct of NCEH/ATSDR
program peer review.
Matters to be Discussed: Discussion of
the peer review of the Air Pollution and
Respiratory Branch; discussion of the
planning for the Division of Toxicology
and Environmental Medicine peer
review; and a discussion of the peer
review process.
Agenda Items are subject to change as
priorities dictate.
SUPPLEMENTARY INFORMATION: This
conference call is scheduled to begin at
12:30 p.m. EST. To participate please
dial (877) 315–6535 and enter
conference code 383520. Public
comment period is scheduled for 1:45–
1:55 p.m.
FOR FURTHER INFORMATION CONTACT:
Sandra Malcom, Committee
Management Specialist, Office of
Science, NCEH/ATSDR, M/S E–28, 1600
Clifton Road, NE., Atlanta, Georgia
30333, telephone 404/498–0003.
E:\FR\FM\30DEN1.SGM
30DEN1
Federal Register / Vol. 70, No. 250 / Friday, December 30, 2005 / Notices
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both CDC and
the National Center for Environmental
Health/Agency for Toxic Substances
and Disease Registry.
Dated: December 23, 2005.
Elaine Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 05–24639 Filed 12–29–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Institute for Occupational
Safety and Health Advisory Board on
Radiation and Worker Health
wwhite on PROD1PC61 with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following committee
meeting:
Name: Working Group of the Advisory
Board on Radiation and Worker Health
(ABRWH), National Institute for
Occupational Safety and Health (NIOSH).
Audio Conference Call Time and Date: 10
a.m.–4 p.m., EST, Monday, January 9, 2006.
Place: Audio conference call via FTS
conferencing. The USA toll-free dial-in
number is 1–888–390–6586, pass code 41964.
Status: Open to the public, but without a
public comment period.
Background: The ABRWH was established
under the Energy Employees Occupational
Illness Compensation Program Act
(EEOICPA) of 2000 to advise the President,
delegated to the Secretary, Department of
Health and Human Services (HHS), on a
variety of policy and technical functions
required to implement and effectively
manage the new compensation program. Key
functions of the Board include providing
advice on the development of probability of
causation guidelines which have been
promulgated by HHS as a final rule, advice
on methods of dose reconstruction which
have also been promulgated by HHS as a
final rule, advice on the scientific validity
and quality of dose estimation and
reconstruction efforts being performed for the
purposes of the compensation program, and
advice on petitions to add classes of workers
to the Special Exposure Cohort (SEC).
In December 2000, the President delegated
responsibility for funding, staffing, and
operating the Board to HHS, which
subsequently delegated this authority to CDC.
NIOSH implements this responsibility for
CDC. The charter was issued on August 3,
VerDate Aug<31>2005
18:16 Dec 29, 2005
Jkt 208001
2001 and renewed at appropriate intervals,
and will expire on August 3, 2007.
Purpose: The Board is charged with (a)
providing advice to the Secretary, HHS, on
the development of guidelines under
Executive Order 13179; (b) providing advice
to the Secretary, HHS, on the scientific
validity and quality of dose reconstruction
efforts performed for this program; and (c)
upon request by the Secretary, HHS, advise
the Secretary on whether there is a class of
employees at any Department of Energy
facility who were exposed to radiation but for
whom it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such radiation
doses may have endangered the health of
members of this class.
Matters to be Discussed: Agenda for the
conference call includes reviews of the
Bethlehem Steel Site Profile, Y–12 Site
Profile, a report from the working group
regarding discussions concerning the Board’s
review of SEC petitions, and science issues.
The agenda is subject to change as
priorities dictate.
In the event a member cannot attend,
written comments may be submitted. Any
written comments received will be provided
at the meeting and should be submitted to
the contact person below well in advance of
the meeting.
For Further Information Contact: Dr. Lewis
V. Wade, Executive Secretary, NIOSH, CDC,
4676 Columbia Parkway, Cincinnati, Ohio
45226, telephone 513/533–6825, fax 513/
533–6826.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: December 22, 2005.
Diane Allen,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 05–24640 Filed 12–29–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Institute for Occupational
Safety and Health (NIOSH) of the
Centers for Disease Control and
Prevention (CDC) Announces the
Following Meeting and Opening of the
Public Comment Period
Name: The Draft Document: NIOSH
Current Intelligence
Bulletin: Evaluation of Health Hazard
and Recommendations for Occupational
Exposure to Titanium Dioxide.
Meeting Date and Time: February 27,
2006, 9 a.m.–4 p.m.
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
77399
Place: Robert A. Taft Laboratories,
Taft Auditorium, NIOSH, CDC, 4676
Columbia Parkway, Cincinnati, Ohio
45226.
Purpose: To explain and discuss the
scientific basis for the draft document,
‘‘NIOSH Current Intelligence Bulletin:
Evaluation of Health Hazard and
Recommendations for Occupational
Exposure to Titanium Dioxide,’’ current
research on titanium dioxide, and
information on occupational exposure
to titanium dioxide. Special emphasis
will be placed on discussion of the
following:
(1) What animal and human data best
describe the health concerns from
exposure to titanium dioxide; (2) What
strategies are being used to control
occupational exposure to titanium
dioxide (e.g., engineering controls, work
practices, personal protective
equipment); (3) In which workplaces
and occupations can exposure to
titanium dioxide occur; (4) What
challenges exist in measuring workplace
exposures to titanium dioxide; (5) What
are areas for future collaborative efforts
(e.g., research, communication,
development of exposure measurement
and control strategies)?
The public is invited to attend and
will have the opportunity to provide
comments.
NIOSH seeks to obtain materials,
including published and unpublished
reports and research findings, to
evaluate the possible health risks of
occupational exposure to titanium
dioxide (including particle size-specific
information). Examples of requested
information include, but are not to be
limited to, the following: (1)
Identification of industries or
occupations in which exposures to
titanium dioxide may occur; (2) Trends
in the production and use of titanium
dioxide; (3) Description of work tasks
and scenarios with a potential for
exposure to titanium dioxide; (4)
Current and historical exposure
measurement data in various types of
industries and jobs; (5) Case reports or
other health information demonstrating
health effects in workers exposed to
titanium dioxide; (6) Reports of
experimental in vivo and in vitro
studies that provide evidence of a doserelationship between the particle size of
a substance and its biological activity;
(7) Reports of experimental inhalation
studies with rodents demonstrating a
relationship between the particle size or
surface area of a substance and lung
inflammation, fibrosis, and biochemical
mediators; (8) Description of work
practices and engineering controls used
to reduce or prevent workplace
exposure to titanium dioxide. (9)
E:\FR\FM\30DEN1.SGM
30DEN1
Agencies
[Federal Register Volume 70, Number 250 (Friday, December 30, 2005)]
[Notices]
[Pages 77398-77399]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-24639]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
National Center for Environmental Health/Agency for Toxic
Substances and Disease Registry
The Program Peer Review Subcommittee of the Board of Scientific
Counselors (BSC), Centers for Disease Control and Prevention (CDC),
National Center for Environmental Health/Agency for Toxic Substances
and Disease Registry (NCEH/ATSDR): Teleconference.
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), The Centers for Disease Control and
Prevention, NCEH/ATSDR announces the following subcommittee meeting:
Name: Program Peer Review Subcommittee (PPRS).
Times and Dates: 12:30 p.m.-2 p.m., January 23, 2006.
Place: The teleconference will originate at the National Center for
Environmental Health/Agency for Toxic Substances and Disease Registry
in Atlanta, Georgia. Please see SUPPLEMENTARY INFORMATION for details
on accessing the teleconference.
Status: Open to the public, teleconference access limited only by
availability of telephone ports.
Purpose: Under the charge of the BSC, NCEH/ATSDR the PPRS will
provide the BSC, NCEH/ATSDR with advice and recommendations on NCEH/
ATSDR program peer review. They will serve the function of organizing,
facilitating, and providing a long-term perspective to the conduct of
NCEH/ATSDR program peer review.
Matters to be Discussed: Discussion of the peer review of the Air
Pollution and Respiratory Branch; discussion of the planning for the
Division of Toxicology and Environmental Medicine peer review; and a
discussion of the peer review process.
Agenda Items are subject to change as priorities dictate.
SUPPLEMENTARY INFORMATION: This conference call is scheduled to begin
at 12:30 p.m. EST. To participate please dial (877) 315-6535 and enter
conference code 383520. Public comment period is scheduled for 1:45-
1:55 p.m.
FOR FURTHER INFORMATION CONTACT: Sandra Malcom, Committee Management
Specialist, Office of Science, NCEH/ATSDR, M/S E-28, 1600 Clifton Road,
NE., Atlanta, Georgia 30333, telephone 404/498-0003.
[[Page 77399]]
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities for
both CDC and the National Center for Environmental Health/Agency for
Toxic Substances and Disease Registry.
Dated: December 23, 2005.
Elaine Baker,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 05-24639 Filed 12-29-05; 8:45 am]
BILLING CODE 4163-18-P